UPDATE: Indianapolis preparing to sue opioid makers, distributors
The city of Indianapolis plans to file a “robust lawsuit” against several drug companies, Mayor Joe Hogsett announced Thursday morning.
Health Care & Life Sciences
Articles
Struggling Endocyte spending millions for rights to prostate-cancer drug
After struggling for more than 20 years to develop cancer drugs without success, West Lafayette-based Endocyte Inc. is pausing it own R&D efforts to concentrate on a potential blockbuster drug from a German chemical company.
FDA approves Lilly drug for common advanced breast cancer
U.S. regulators have approved a new medicine for treating a common type of breast cancer after it has spread to other parts of the body.
FDA’s consumer protection warnings falling under Trump
From January to July, the agency sent 265 warning letters to companies, notifying them of what it alleged to be serious violations of federal rules. That’s the lowest tally for the first seven months of any year since 2008.
Opioid-abusers on payroll create risks at workplace
Castlight Health, a benefits platform, estimates that opioid abusers cost employers nearly twice as much in health-care expenses as their clean co-workers—an extra $8,600 a year.
EILENBERG: Is pharma the cause or solution to the opioid crisis?
Unfortunately, what started as a solution for pain turned into a crisis that is killing people.
Health Care & Benefits Power Breakfast: Panelists discuss ER care, nutrition, opiates and more
A sampling of panelists’ conversation at IBJ’s Sept. 21 Health Care & Benefits Power Breakfast.
Indiana rates to climb more than 20 percent on Obamacare exchanges
Hoosiers buying health insurance on the Obamacare marketplace will pay an average of nearly $500 a month in premiums next year, a sharp rise over current rates.
LifeOmic teams with IU, Regenstrief on precision medicine
The startup, founded by serial entrepreneur Don Brown, has hashed out a deal that it gives it access to a broad range of intellectual property.
GOP concedes on last-gasp attempt to repeal Obamacare
Senate Republicans, short of votes, abandoned their latest and possibly final attempt to kill the health care law Tuesday, just ahead of a critical end-of-the-week deadline.
Ex-American Senior Communities CFO who avoided indictment blasted in new lawsuit
Roger Werner played a “central role” in helping fellow executives fleece the nursing home company, according to a new federal lawsuit.
Indiana health leaders brace for possible Obamacare repeal
Health experts at an IBJ Health Care & Benefits panel discussion on Thursday said passage of the Graham-Cassidy bill could challenge Indiana's ability to care for low-income Hoosiers.
Holcomb signs letter backing Senate GOP’s health care bill
Indiana Gov. Eric Holcomb has joined 14 other Republican governors in backing a last-ditch GOP effort to repeal former President Barack Obama's signature health care law.
Anthem buys Florida insurer in first acquisition since Cigna deal failed
The deal for HealthSun gives Anthem another 40,000 members and helps build its base in south Florida.
Walgreens, Rite Aid revise store purchase deal to $4.38B
Walgreens and Rite Aid have finally devised a combination of the nation's largest and third-largest drugstore chains that will get past antitrust regulators.
Cook Group selling drug unit for $950M, buying former GE factory
Cook officials cast the sale of Cook Pharmica and the purchase of what once was the world’s largest refrigerator factory as good news for Bloomington.
Longtime OB-GYN named new Indiana state health commissioner
Dr. Kristina Box will take over Indiana’s top health job next month, succeeding Dr. Jerome Adams, who resigned to become U.S. surgeon general.
Anthem expands Obamacare options in Virginia to fill holes
Anthem Inc. reversed course and said it will offer Obamacare plans in Virginia, after a pullback by another insurer threatened to leave the state with large gaps in coverage.
Analysts see Trump threats to insurers boosting premiums
Average premiums for individually purchased health insurance will grow around 15 percent next year, the Congressional Budget Office projected.
Anthem weighs retreating from even more Obamacare markets
The Indianapolis-based health insurer is in talks with officials in some states ahead of deadlines later this month to decide whether to sell coverage in 2018, CEO Joseph Swedish said Tuesday.